Sunday 18 October 2026
Export NUWE’s income statement to Excel — free account
Nuwellis, Inc.
NUWE Healthcare Medical Devices
Nuwellis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.3 million, down 5.38% from fiscal 2024. In the quarter to June 2026, revenue grew 14.1%, EPS grew 98.8% and free cash flow fell 51.6%, each against the same quarter a year earlier.
0.55
0.00
0.00%
Follow NUWE
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
4 | 4 | 5 | 4 | 5 | — | — | — | — | 3 |
P/S ratio |
9,819,696,209.25 | 103,927,553.22 | 85,588,590.18 | 1,951,010.89 | 7,947,078.16 | 0.00 | 0.00 | 0.00 | 0.17 | 0.15 |
Altman Z-Score |
1,718,305,953.32 | 97,126,445.15 | 90,374,281.47 | 1,785,986.11 | 9,604,888.78 | — | — | — | (44.17) | (76.39) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(88.11) | (24.31) | (80.96) | (146.91) | (34.19) | (19.97) | (34.15) | (104.20) | (99.99) | (177.65) |
Beneish M-Score |
— | (1.13) | 0.28 | (1.61) | (2.27) | (2.15) | (1.80) | (2.96) | (3.46) | (7.71) |
P/Operating CF |
(5,487,371,461.75) | (117,186,479.41) | (157,442,684.47) | (2,667,995.29) | (17,346,497.08) | 0.00 | 0.00 | 0.00 | (0.98) | (0.40) |
P/B ratio |
8,523,071,553.27 | 22,740,152.52 | 72,063,978.05 | 5,403,025.63 | 3,623,863.74 | 0.00 | 0.00 | 0.00 | 0.23 | 0.46 |
Price to Tangible BV |
0.00 | 30,187,589.65 | 221,643,406.06 | 0.00 | 4,802,973.40 | 0.00 | 0.00 | 0.00 | 0.58 | 0.00 |
EV/Sales |
9,819,696,212.25 | 103,927,550.50 | 85,588,590.26 | 1,951,011.42 | 7,947,076.75 | (2.56) | (1.68) | 0.02 | 0.04 | 0.49 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.06 | 0.85 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(919,165,033.37) | (30,977,733.80) | (29,379,929.54) | (656,933.09) | (3,568,319.94) | 1.13 | 0.95 | (0.01) | (0.03) | (0.38) |
EV/FCF |
(912,611,172.14) | (30,301,541.68) | (28,985,755.12) | (637,837.33) | (3,511,740.49) | 1.12 | 0.94 | (0.01) | (0.03) | (0.37) |
Quick Ratio |
0.49 | 7.72 | 2.21 | 0.62 | 4.28 | 7.55 | 4.20 | 1.81 | 2.67 | 0.85 |
Current Ratio |
0.74 | 8.54 | 2.86 | 1.20 | 5.17 | 8.51 | 4.86 | 2.59 | 3.46 | 1.71 |
Net Debt/EBITDA |
0.09 | 1.55 | 0.33 | 0.06 | 0.86 | 1.27 | 1.09 | 0.22 | 0.48 | 0.10 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 4.66% | 0.27% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.08 | 0.27 | 0.37 | 0.77 | 0.58 | 0.31 | 0.31 | 0.51 | 0.89 | 1.03 |
Operating CF/Net income |
0.92 | 0.48 | 0.85 | 0.72 | 0.94 | 0.91 | 1.04 | 0.79 | 0.90 | 0.62 |
Capex/Depreciation |
(0.13) | (0.05) | (0.85) | (2.05) | (0.71) | (0.45) | (0.33) | (0.69) | (0.19) | (0.45) |
Interest Coverage |
(31.08) | — | — | — | — | — | (1.86) | (5.06) | (1.96) | (1.05) |
| (254.05%) | (277.54%) | (153.62%) | (570.86%) | (192.19%) | (92.53%) | (75.84%) | (294.87%) | (223.24%) | (382.80%) | |
| (110.85%) | (192.64%) | (125.09%) | (314.69%) | (137.37%) | (77.55%) | (52.73%) | (131.39%) | (108.22%) | (219.21%) | |
ROIC |
(1,065.15%) | (1,439.74%) | (2,334.98%) | (1,164.22%) | (550.00%) | (689.48%) | 0.00% | 0.00% | (478.57%) | (449.27%) |
Return on Tangible Assets |
5,877.74% | (152.80%) | (292.50%) | (1,349.82%) | (108.93%) | (75.19%) | (76.20%) | (392.49%) | (156.83%) | (694.57%) |
Average Days of Receivables |
79.85 | 55.99 | 57.40 | 52.92 | 44.39 | 34.56 | 60.07 | 80.34 | 72.12 | 65.89 |
Research and Development Expense of Revenue |
629.09% | 41.68% | 61.08% | 84.78% | 49.29% | 62.85% | 50.83% | 61.17% | 36.72% | 32.79% |
Selling, General and Administrative Expense of Revenue |
630.64% | 286.24% | 306.34% | 295.50% | 234.07% | 240.36% | 205.83% | 193.94% | 153.95% | 163.46% |
Intangible Assets out of Total Assets |
0.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
73.62% | 14.04% | 41.76% | 27.44% | 18.13% | 16.59% | 10.09% | 7.56% | 5.47% | 1.54% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.76 | 1.42 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(0.22%) | (13.00%) | (94.44%) | (883.50%) | (175.35%) | (35.91%) | (1,179.59%) | (1,947.61%) | (3,882.71%) | (5,220.16%) |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (658.14%) | (911.62%) |
Revenue per Share |
39.06 | 74.02 | 12.37 | 68.04 | 4.51 | 0.00 | 0.00 | 0.00 | 9,711.11 | 419.80 |
Operating CF per Share |
(493.70) | (248.33) | (36.04) | (202.06) | (10.05) | 0.00 | 0.00 | 0.00 | (10,656.67) | (548.73) |
Capex per Share |
(3.55) | (5.40) | (0.49) | (6.05) | (0.16) | 0.00 | 0.00 | 0.00 | (66.67) | (4.57) |
Free Cash Flow per Share |
(497.24) | (253.73) | (36.53) | (208.11) | (10.21) | 0.00 | 0.00 | 0.00 | (10,723.33) | (553.30) |
Cash per Share |
40.09 | 324.90 | 13.56 | 15.79 | 8.76 | 0.00 | 0.00 | 0.00 | 5,661.11 | 55.08 |
Shareholders Equity per Share |
67.94 | 338.29 | 14.69 | 24.57 | 9.90 | 0.00 | 0.00 | 0.00 | 7,255.56 | 133.50 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
67.94 | 338.29 | 14.69 | 24.57 | 9.90 | 0.00 | 0.00 | 0.00 | 7,255.56 | 133.50 |
Free Cash Flow |
(16.41) | (12.18) | (14.76) | (16.86) | (16.84) | (18.06) | (15.27) | (18.18) | (9.65) | (10.90) |
Working Capital |
(0.84) | 15.77 | 5.29 | 0.69 | 14.95 | 24.82 | 18.08 | 5.04 | 6.30 | 2.15 |
Capital Expenditures |
(0.12) | (0.26) | (0.20) | (0.49) | (0.27) | (0.22) | (0.12) | (0.25) | (0.06) | (0.09) |
Net Current Asset Value |
(2.81) | 15.65 | 5.29 | 0.42 | 14.84 | 23.66 | 10.45 | 1.65 | 5.52 | 1.70 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.04 | 0.84 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.09 | 0.07 | 0.04 | 0.09 | 0.04 | 0.03 | 0.01 | 0.03 | 0.01 | 0.01 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.64 | 8.28 | 0.43 | 0.24 | 0.31 | 0.41 | 0.38 | 0.50 | 0.65 | 0.54 |
Cash ROIC |
(460.28%) | (38.26%) | (129.27%) | (477.54%) | (54.66%) | (35.99%) | (49.80%) | (259.38%) | (83.02%) | (293.41%) |
Accounts Receivable Turnover |
7.56 | 8.59 | 7.51 | 6.95 | 8.73 | 9.57 | 7.92 | 5.28 | 4.75 | 5.14 |
Accounts Payable Turnover |
0.30 | 1.94 | 3.68 | 2.03 | 2.62 | 2.73 | 2.07 | 1.68 | 1.52 | 1.63 |
Inventory Turnover |
0.63 | 2.44 | 2.26 | 1.54 | 1.42 | 1.18 | 1.38 | 1.67 | 1.65 | 1.73 |
Average Days of Payables |
1,017.19 | 113.87 | 112.68 | 204.18 | 118.32 | 150.47 | 216.32 | 223.83 | 195.37 | 258.26 |
Days of Inventory on Hand |
346.57 | 209.78 | 164.90 | 246.58 | 318.94 | 302.54 | 256.41 | 187.81 | 204.66 | 221.60 |
Average Receivables |
0.17 | 0.41 | 0.67 | 0.79 | 0.85 | 0.83 | 1.08 | 1.68 | 1.84 | 1.61 |
Average Payables |
2.41 | 1.42 | 1.00 | 1.31 | 1.29 | 1.26 | 1.83 | 2.31 | 2.01 | 1.93 |
Average Inventory |
1.13 | 1.13 | 1.62 | 1.73 | 2.38 | 2.90 | 2.75 | 2.33 | 1.86 | 1.81 |
Average Assets |
15.96 | 12.96 | 13.62 | 7.19 | 12.81 | 25.21 | 27.55 | 17.22 | 9.82 | 7.99 |
Average Common Equity |
6.96 | 9.00 | 11.09 | 3.96 | 9.15 | 21.13 | 19.15 | 7.67 | 4.76 | 4.58 |
Columns are period end dates